"Abu Dhabi stem cells" and"Yas Klink" They succeed in applying the treatment of genetically modified immune cells
Abu Dhabi, September 25/ WAM/ The Abu Dhabi Stem Cell Center “ADSCC”, in cooperation with Yas Klink Hospital-Khalifa City, succeeded in applying the treatment of genetically modified immune cells “CAR-T” to a 38-year-old patient, who suffers from the SLE “SLE” and the syndrome of phospholipid triglycerides “APS”, which is a highly complex autonomous condition And risk.
The patient was suffering from multiple complications due to this condition, and despite receiving immunosuppressive treatments and anticoagulants, the disease continued his activity and became a direct threat to his life.
Professor Yandari Ventura, CEO of the Abu Dhabi Stem Cell Center, said that the success of the “Car-T” treatment application for this complex condition represents a qualitative step towards a new future in the treatment of self-immune diseases, and reflects years of research, innovation and medical care centered around the patient.
For her part, Dr. Mason Al Karam, Executive Director of Medical Affairs at Yas Klink Hospital – Khalifa City, stressed that this medical achievement reflects the continuous progress in the application of the treatment of immune cells for complex self -immune diseases, and sets new criteria for treating cases that have exhausted traditional treatment options.
This success confirms the potential for cellular therapy in renewal medicine and its role in improving the lives of patients who do not respond to traditional treatments. It also reflects the leadership of the UAE in global medical innovation and enhances its position as an advanced position in advanced health care.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
